| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 109.80B | 115.68B | 118.79B | 112.73B | 108.79B | 108.53B |
| Gross Profit | 40.52B | 40.15B | 36.77B | 31.17B | 39.61B | 41.41B |
| EBITDA | 12.01B | 9.11B | 8.57B | 4.43B | 16.46B | 16.36B |
| Net Income | 7.29B | 5.22B | 4.56B | 1.79B | 10.95B | 10.23B |
Balance Sheet | ||||||
| Total Assets | 73.83B | 70.77B | 80.59B | 75.92B | 73.79B | 71.64B |
| Cash, Cash Equivalents and Short-Term Investments | 18.04B | 24.36B | 31.66B | 20.02B | 21.79B | 32.04B |
| Total Debt | 9.00B | 12.74B | 15.82B | 10.11B | 2.90B | 6.75B |
| Total Liabilities | 38.21B | 39.91B | 44.62B | 35.43B | 30.29B | 33.95B |
| Stockholders Equity | 35.61B | 30.86B | 35.97B | 40.49B | 43.50B | 37.69B |
Cash Flow | ||||||
| Free Cash Flow | 11.98B | 7.41B | 15.16B | -2.60B | -1.76B | 13.35B |
| Operating Cash Flow | 13.82B | 8.33B | 17.48B | -1.06B | -235.53M | 14.58B |
| Investing Cash Flow | -2.30B | -2.27B | -2.28B | -3.14B | -1.37B | -1.38B |
| Financing Cash Flow | -11.90B | -13.17B | -6.43B | 1.07B | -10.52B | -4.05B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥149.34B | 2.97 | 12.77% | 2.84% | 4.48% | 22.39% | |
76 Outperform | ¥148.33B | 22.89 | ― | 1.92% | 7.46% | -8.01% | |
72 Outperform | ¥98.46B | 8.23 | 22.46% | 4.06% | -8.93% | 48.98% | |
69 Neutral | ¥4.12T | 12.61 | ― | 3.27% | 4.02% | -41.52% | |
67 Neutral | ¥618.05B | 9.47 | 6.07% | 3.69% | 0.48% | 6.92% | |
67 Neutral | ¥87.00B | 11.91 | ― | 4.76% | 1.81% | 9.07% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |